Cigna's earnings report is coming soon, so investors are on edge. Will Cigna surpass Wall Street's estimates, or will it fall ...

In a turbulent market, Blackstone Inc showcased a robust Q2 2025, with a sharp increase in assets under management (AUM) and ...

Thermo Fisher Scientific Inc. just made headlines with its hefty $17.6 billion acquisition of PPD, Inc., aiming to bolster ...

Analysts predict that Starbucks' upcoming quarterly earnings will drop to $0.64 per share. This represents a 31.2% decrease ...

In the first quarter, Kathleen S. Wright Associates Inc. slashed its stake in Johnson & Johnson by a hefty 21.1%, unloading 1 ...

UBS Group recently elevated its price target on RTX from $166.00 to $177.00, signaling a robust 14.05% potential upside, ...

Visa faces a regulatory reckoning in Switzerland over interchange fees. The Swiss Competition Commission's (ComCo) actions ...

On July 24, 2025, Oracle's trading volume soared to 19.94 billion, securing a 37th place in market rankings. The stock price ...

Abbott Laboratories might just be the prescription for your portfolio. The company is sitting pretty thanks to strong ...

JPMorgan Chase & Co. has upped the ante for Texas Instruments, raising its price target from $195.00 to $225.00, signaling a ...

Seaport Res Ptn has updated its Q3 earnings forecast for Morgan Stanley, pushing the EPS estimate from $2.03 to $2.09. This ...

UBS remains bullish on Merck, reiterating its Buy rating with a $105 price target. This optimism follows Merck's planned $10 ...